KatrinaA(Gwinn-Hardy)GwinnMD

Neurology • Bethesda, MD

Movement Disorder

Program Director and Medical Officer

Join to view full profile

Dr. Gwinn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Gwinn's full profile

Already have an account?

Office
NINDS-NIH 6001 Executive Blvd
2143
Bethesda, MD 20892
Phone+1 301-496-5745

Fax+1 301-402-1501
Is this information wrong?

Summary

I am a board-certified Neurologist, and Movement disorders specialist, with a track record of an academic career in human gene discovery (Neurodegenerative diseases). I am a Medical Officer managing grants and contracts for the National Institute of Neurological Disorders and Stroke (NINDS) at the NIH. I do not currently have a clinical practice. In the past I have worked clinically in both academics and private practice. Projects I have managed and am managing include the NINDS Human DNA and Cell Line Repository, The NINDS Parkinson's Disease Biomarkers Program, and the North American Mitochondrial Disease Consortium, among many others.

Education & Training

Mayo Clinic Hospital1995 - 1996
University of Michigan Health SystemResidency, Neurology, 1992 - 1995
Vanderbilt University Medical CenterInternship, Internal Medicine, 1991 - 1992
Vanderbilt University School of MedicineClass of 1991
Wellesley CollegeB.A, Psychobiology, 1978 - 1982

Certifications & Licensure

MD State Medical License 2001 - 2024
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

NIH NINDS Group Merit Award BioFIND, 2012
NIH NINDS Group Merit Award Parkinson’s Disease Biomarkers Program, 2012
Hall of Fame for Distinguished Alumni Atherton Alumni Association, 2009
NIH Directors Award Genome Wide Association Studies Policy Committee, 2008
NIH NIMH Directors Award Normal Brain Development Contract, 2006
American Neurological Association 2005
NIH Director's Award Trans-NIH Muscular Dystrophy Working Group, 2004
NIH NINDS Merit Award NINDS Genetics Repository (Project Officer), 2004
NIH NINDS Group Merit Award Communications and Public Liaison, 2002
Best Doctors in America 1998, 2001, 2005, 2007
Travel Award National Spasmodic Torticollis Association, 1995
Amos Christie Award in Pediatrics Vanderbilt University School of Medicine, 1990
Wellesley Scholar 1982
Join now to see all

Publications & Presentations

PubMed

74 citations
Finding useful biomarkers for Parkinson’s disease
Alice Chen-Plotkin, Roger L. Albin, Roy N. Alcalay, Debra Babcock, Vikram Singh Bajaj, Dubois Bowman, Alex Buko, Jesse M. Cedarbaum, Daniel Chelsky, Mark R. Cookson, T...> ;Science Translational Medicine. 2018 Aug 15
98 citations
Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features.
Jennifer G. Goldman, Howard Andrews, Amy W. Amara, Anna Naito, Roy N. Alcalay, Leslie M. Shaw, Peggy Taylor, Tao Xie, Paul J. Tuite, Claire Henchcliffe, Penelope Hogar...> ;Movement Disorders. 2018 Feb 1
71 citations
Excess α-synuclein compromises phagocytosis in iPSC-derived macrophages
Walther Haenseler, Federico Zambon, Heyne Lee, Jane Vowles, Federica Rinaldi, Galbha Duggal, Henry Houlden, Katrina Gwinn, Selina Wray, Kelvin C. Luk, Richard Wade-Mar...> ;Scientific Reports. 2017 Aug 21
41 citations
Parkinson's disease biomarkers: Perspective from the NINDS Parkinson's Disease Biomarkers Program
Katrina Gwinn, Karen K. David, Christine Swanson-Fischer, Roger L. Albin, Coryse St Hillaire-Clarke, Beth Anne Sieber, Codrin Lungu, F. DuBois Bowman, Roy N. Alcalay, ...> ;Biomarkers in Medicine. 2017 Jun 23
39 citations
Knowledge gaps and research recommendations for essential tremor
Franziska Hopfner, Dietrich Haubenberger, Wendy R. Galpern, Katrina Gwinn, Ashlee Van't Veer, Samantha L. White, Kailash P. Bhatia, Charles H. Adler, David Eidelberg, ...> ;Parkinsonism & Related Disorders. 2016 Dec 1
32 citations
Nutritional interventions in primary mitochondrial disorders: Developing an evidence base.
Kathryn M. Camp, Danuta Krotoski, Melissa A. Parisi, Katrina Gwinn, Bruce H. Cohen, Christine S. Cox, Gregory M. Enns, Marni J. Falk, Amy Goldstein, Rashmi Gopal-Sriva...> ;Molecular Genetics and Metabolism. 2016 Nov 1
70 citations
The NINDS Parkinson's disease biomarkers program
Liana S. Rosenthal, Daniel Drake, Roy N. Alcalay, Debra Babcock, F. DuBois Bowman, Alice Chen-Plotkin, Ted M. Dawson, Richard B. Dewey, Dwight C. German, Xuemei Huang,...> ;Movement Disorders. 2016 Jun 1
41 citations
The BioFIND study: Characteristics of a clinically typical Parkinson's disease biomarker cohort.
Un Jung Kang, Jennifer G. Goldman, Roy N. Alcalay, Tao Xie, Paul J. Tuite, Claire Henchcliffe, Penelope Hogarth, Amy W. Amara, Samuel Frank, Alice Rudolph, Cindy Casac...> ;Movement Disorders. 2016 Jun 1
171 citations
Loci associated with ischaemic stroke and its subtypes (SiGN) : A genome-wide association study
Sara L. Pulit, Patrick F. McArdle, Quenna Wong, Rainer Malik, Katrina Gwinn, Sefanja Achterberg, Ale Algra, Philippe Amouyel, Christopher D. Anderson, Donna K. Arnett,...> ;The Lancet. Neurology. 2016 Feb 1
143 citations
Diagnosis of Parkinson's disease on the basis of clinical and genetic classification: a population-based modelling study
Mike A. Nalls, Cory Y. McLean, Jacqueline Rick, Shirley Eberly, Samantha J. Hutten, Katrina Gwinn, Margaret Sutherland, Maria Martinez, Peter Heutink, Nigel Williams, ...> ;The Lancet. Neurology. 2015 Oct 1
58 citations
Mitochondrial Disease Sequence Data Resource (MSeqDR): A global grass-roots consortium to facilitate deposition, curation, annotation, and integrated analysis of genom...
Marni J. Falk, Lishuang Shen, Michael A. Gonzalez, Jeremy Leipzig, Marie T. Lott, Alphons P. M. Stassen, Maria Angela Diroma, Daniel Navarro-Gomez, Philip E. Yeske, Re...> ;Molecular Genetics and Metabolism. 2015 Mar 1
48 citations
Defining neurodegeneration on Guam by targeted genomic sequencing.
John C. Steele, Ilaria Guella, Chelsea Szu-Tu, Michelle K. Lin, Christina Thompson, Daniel M. Evans, Holly E. Sherman, Carles Vilariño-Güell, Katrina Gwinn, Huw R. Mor...> ;Annals of Neurology. 2015 Mar 1
37 citations
Pathogenic Ischemic Stroke Phenotypes in the NINDS-Stroke Genetics Network.
Hakan Ay, Ethem Murat Arsava, Gunnar Andsberg, Thomas Benner, Robert D. Brown, Sherita Chapman, John W. Cole, Hossein Delavaran, Martin Dichgans, Gunnar Engström, Eva ...> ;Stroke. 2014 Dec 1
43 citations
Agreement between TOAST and CCS ischemic stroke classification The NINDS SiGN Study
Patrick F. McArdle, Steven J. Kittner, Hakan Ay, Robert D. Brown, James F. Meschia, Tatjana Rundek, Sylvia Wassertheil-Smoller, Daniel Woo, Gunnar Andsberg, Alessandro...> ;Neurology. 2014 Oct 28
61 citations
Prioritized research recommendations from the National Institute of Neurological Disorders and Stroke Parkinson's Disease 2014 conference
Beth-Anne Sieber, Story C. Landis, Walter J. Koroshetz, Randall J. Bateman, Andrew Siderowf, Wendy R. Galpern, John Dunlop, Steven Finkbeiner, Margaret Sutherland, Hao...> ;Annals of Neurology. 2014 Oct 1
23 citations
Using previously genotyped controls in genome-wide association studies (GWAS): application to the Stroke Genetics Network (SiGN)
Braxton D. Mitchell, Myriam Fornage, Patrick F. McArdle, Yu-Ching Cheng, Sara L. Pulit, Quenna Wong, Tushar Dave, Stephen R. Williams, Roderick A. Corriveau, Katrina G...> ;Frontiers in Genetics. 2014 Apr 29
52 citations
Stroke Genetics Network (SiGN) Study Design and Rationale for a Genome-Wide Association Study of Ischemic Stroke Subtypes
James F. Meschia, Donna K. Arnett, Hakan Ay, Robert D. Brown, Oscar R. Benavente, John W. Cole, Paul I.W. de Bakker, Martin Dichgans, Kimberly F. Doheny, Myriam Fornag...> ;Stroke. 2013 Sep 10
98 citations
Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research
Selina Wray, Matthew Self, Patrick A. Lewis, Jan-Willem Taanman, Natalie S. Ryan, Colin J. Mahoney, Yuying Liang, Michael J. Devine, Una-Marie Sheerin, Henry Houlden, ...> ;Plos One. 2012 Aug 27
126 citations
Parkinson's disease and α‐synuclein expression
Michael J. Devine, Katrina Gwinn, Andrew B. Singleton, John Hardy> ;Movement Disorders. 2011 Oct 1
32 citations
Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α-synuclein triplication (Iowa kindred).
Katrina Gwinn, Michael J. Devine, Lee-Way Jin, Janel O. Johnson, Thomas D. Bird, Manfred D. Muenter, Cheryl Waters, Charles H. Adler, Richard J. Caselli, Henry Houlden...> ;Movement Disorders. 2011 Sep 1
344 citations
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus
Michael J. Devine, Mina Ryten, Petr Vodicka, Alison J. Thomson, Tom Burdon, Henry Houlden, Fatima Cavaleri, Masumi Nagano, Nicola J. Drummond, Jan-Willem Taanman, Anth...> ;Nature Communications. 2011 Aug 23
95 citations
Common Data Elements for Traumatic Brain Injury: Recommendations From the Biospecimens and Biomarkers Working Group
Geoffrey T. Manley, Ramon Diaz-Arrastia, Mary Brophy, Doortje C. Engel, Clay Goodman, Katrina Gwinn, Timothy D. Veenstra, Geoffrey S.F. Ling, Andrew K. Ottens, Frank C...> ;Archives of Physical Medicine and Rehabilitation. 2010 Nov 1
26 citations
CoAIMs: A Cost-Effective Panel of Ancestry Informative Markers for Determining Continental Origins
Eric Londin, Margaret A. Keller, Cathleen Maista, Gretchen Smith, Laura A. Mamounas, Ran Zhang, Steven J. Madore, Katrina Gwinn, Roderick A. Corriveau> ;Plos One. 2010 Oct 15
1 citations
Protected to Death
John Hardy, Katrina Gwinn> ;Journal of Alzheimer's Disease. 2010 Jan 1
1444 citations
Genome-wide association study reveals genetic risk underlying Parkinson's disease
Javier Simón-Sánchez, Claudia Schulte, Jose Bras, Manu Sharma, J. Raphael Gibbs, Daniela Berg, Coro Paisán-Ruiz, Peter Lichtner, Sonja W. Scholz, Dena G. Hernandez, Re...> ;Nature Genetics. 2009 Dec 1
Join now to see all

Journal Articles

Who is counseling the pregnant women who smoke?
Waddlington WB, Gwinn KA, Riley HD, J Tenn Med Assoc
A golden opportunity-motivating smoking cessation in parents.
Waddlington WB, Gwinn KA, Riley HD, J Tenn Med Assoc
A 73 year old man with gait disturbance and imbalance.
Evidente VH, Gwinn KA, Mayo Clin Proc
Low frequency of alpha-synuclein mutations in familial Parkinson’s disease.
Farrer M, Wavrant DeVrieze F, Crook R, Boles L, Perez-Tur J, Hardy J, Johnson WG, Steele J, Maraganore D, Gwinn K, Lynch T, Ann Neurol
80 year old woman with dementia and parkinsonism.
Evidente V, Gwinn K, Mayo Clin Proc
Electrophysiological observations in idiopathic opsoclonus-myoclonus syndrome.
Gwinn KA, Caviness JN, Mov Disord
Risperidone induced tardive dyskinesia and parkinsonism.
Gwinn KA, Caviness JN, Mov Disord
Biofeedback for Writer’s Cramp.
O’Neill MA, Gwinn KA, Adler CH, Am J Occup Ther
Orthostatic tremor responsive to gabapentin.
Evidente VG, Adler CH, Caviness JN, Gwinn KA, Mov Dis
Post-encephalitic parkinsonism.
Evidente VGH, Gwinn KA, J Neurol Neurosurg Psychiatry
Surgically responsive focal tremor disorder due to a small frontal convexity meningioma.
Evidente VGH, Gwinn KA, Caviness JN, Hirschorn K, Deen G, Eur Neurol
Exclusion of genetic linkage to 4q21-23 and 17q21 in a family with Lewy body parkinsonism.
Hardy J, Perez-Tur J, Baker M, Farrer M, Crook R, Hutton M, Johnson WG, Gwinn K, Muenter M, Rocca W, Maraganore D, Am J Med Genetics
Olfactory Function in Restless Legs Syndrome.
Adler CH, Gwinn KA, Cox SJ, Mov Dis
The effect of temperature on hand function in patients with tremor.
Cooper C, Evidente VG, Hentz JG, Adler CH, Caviness JN, Gwinn-Hardy K, J Hand Ther
A repository for neurological gene discovery.
Gwinn-Hardy, K., and Beck, J.C, Eur. J. Hum. Genet
Priorities for hydrocephalus research: report from a National Institutes of Health-sponsored workshop.
Williams MA, McAllister JP, Walker ML, Kranz DA, Bergsneider M, Del Bigio MR, Fleming L, Frim DM, Gwinn K, Kestle JR, Luciano MG, Madsen JR, Oster-Granite ML, Spinella G, J Neurosurg
Clinical features, with video documentation, of the original familial lewy body Parkinsonism causes by alpha-synuclein triplication (Iowa kindred).
Gwinn K, Devine MJ, Jin LW, Johnson J, Bird T, Muenter M, Waters C, Adler CH, Caselli R, Houlden H, Lopez G, Singleton A, Hardy J, Singeton A, Mov Disord
Parkinson’s disease induced pluripotent stem cells with triplication of the alpha-synuclein locus.
Devine MJ, Ryten M, Vodicka P, Thomson AJ, Burdon T, Houlden H, Cavaleri F, Nagano M, Drummond NJ, Taanman J-W, Schapira AH, Gwinn K, Hardy J, Lewis PA, Kunath T, Nat Commun
Parkson’s disease and alpha-synuclein expression.
Devine MJ, Gwinn K, Singleton A, Hardy J, Mov Disord
Creation of an Open-Access, Mutation-Defined Fibroblast Resource for Neurological Disease Research.
Wray S, Self M, NINDS Parkinson’s Diseae iPSC Consortium, NINDS Huntington’s Disease iPSC Consortium, NINDS ALS iPSC Consortium, Lewis PA, Taanman J-W, Ryan NS, Mahone..., Plos One
Diagnostic Criteria for Psychosis in Parkinson’s disease: Report of an NINDS/NIMH Work Group.
Ravina B, Marder K, Fernandez H, Friedman J, McDonald MD W, Murphy D, Aarsland D, Babcock D, Cummings J, Endicott J, Factor S, Galpern W, Lees A, Marsh L, Stacy M, G..., Mov Disord
BDNF tagging polymorphisms and haplotype analysis in sporadic Parkinson's disease in diverse ethnic groups.
Xiromerisiou G, Hadjigeorgiou GM, Eerola J, Fernandez HH, Tsimourtou V, Mandel R, Hellström O, Gwinn-Hardy K, Okun MS, Tienari PJ, Singleton AB, Neurosci Lett
Deletion at ITPR1 underlies a young-onset autosomal recessive ataxia in mice and a late-onset autosomal domiant ataxia (SCA15) in humans.
van de Leemput J, Chandran J, Knight MA, Holtzclaw LA, Scholz S, Cookson MR, Gwinn-Hardy K, Fung H-C, Lin X, Hernandez D, Simon-Sanchez J, Rafferty I, Hardy J, Storey ..., PLoS Genet
Genomic investigation of Synuclein multiplication and parkinsonism.
Ross RA, Braithwaite AT, Skipper LM, Kachergus J, Hulihan MM, Middleton F, Nishioka K, Fuchs J, Gasser T, Maraganore DM, Adler CA, Larvor L, Chartier-Harlin M-C, Nilss..., Ann Neurol
GCH1 in early-onset Parkinson's disease.
Cobb SA, Wider C, Ross OA, Mata IF, Adler CH, Rajput A, Rajput AH, Wu RM, Hauser R, Josephs KA, Carr J, Gwinn K, Heckman MG, Aasly JO, Lynch T, Uitti RJ, Wszolek ZK, K..., Mov Disord
Join now to see all

Books/Book Chapters

Surgical Treatment of Movement Disorders.
Gwinn KA, Adler CHEditors: Gilman S, Goldstein GW, Waxman SG.Neurobase, LaJolla, CA
Surgical Treatment of Movement Disorders.
Uitti, R, Gwinn-Hardy KA, Adler CHEditors: Neurobase, Gilman S, Goldstein GW, Waxman SG, eds.LaJolla, CA
Wilson’s Disease.
Chapter: Parkinson’s disease and movement disorders: diagnosis and treatment guidelines for the practicing physician
Gwinn-Hardy KAEditors: Adler CH, Ahlskog JE.Humana Press, Totowa, NJ
Familial variants of Parkinson's disease.
Chapter: Mapping the progress of Alzheimer's and Parkinson's disease
Gwinn-Hardy K, Hanson M, Wszolek Z, Adam A, Singleton A, Adler CH, Caviness JN, Bower J, Hickey S, Chen JY, Waseem S, Farrer MEditors: Mizuno Y, Fisher A, Hanin I.Kluver Academic/Plenum Publishers, New York, NY
Racial and ethnic influences on the expression of the genotype in neurodegenerative diseases.
Chapter: Genotype-proteotype-phenotype relationships in neurodegenerative diseases
Gwinn-Hardy KAEditors: Cummings J, Hardy J, Poncet M Christen Y.Spring Verlag, New York
Parkinson’s Disease: Insights from Genetic Causes.
Chapter: Encyclopedic Reference of Genomics and Proteomics in Molecular Medicine
Baptista M, Cookson M, Gwinn-Hardy KEditors: Ganten D, Ruckpaul K.Springer
The relationship between nosology, etiology and pathogenesis in neurodegenerative diseases.
Page 189 - 192Hardy J, Gwinn-Hardy KAHandb Clin Neurol
Pharmacogenetics of Stroke.
Chapter: Current Clinical Trials of Antithrombotic Therapy in Stroke Prevention; Seminars in Cerebrovascular Diseases and Stroke
Gwinn-Hardy, KEditors: Jose Biller.
The Genetics of Parkinson’s Disease.
Chapter: The Encyclopedia of Movement Disorders
Corriveau RA, Gubitz AK, Gwinn, KEditors: Chris Goetz.Elsevier, Oxford
The Genetics of Parkinsonism.
Chapter: The Encyclopedia of Movement Disorders
Gubitz, A.K., Corriveau, R.A., Gwinn, KEditors: Chris Goetz.Elsevier, Oxford
The Woman Doctor's Guide to Health and Healing.
Page 51 - 52Alzheimer's and Parkinson'sOxmoor House
Join now to see all

Abstracts/Posters

Racial differences in the expression of neurodegenerative disease: Machado-Joseph disease in Caucasians and Africans.
Subramony SH, Hernandez D, Adam A, Smith-Jefferson S, Hussey J, Gwinn-Hardy K, Lynch T, McDaniel O, Hardy J, Farrer M, Singleton A, Mov Disord
A family with a tau P301L mutation presenting with parkinsonism.
Walker RH, Friedman J, Weiner J, Hobler R, Gwinn-Hardy K, Adam A, DeWolfe J, Gibbs R, Baker M, Farrer F, Hutton M, Hardy J, Parkinsonism Rel Dis
Neuropathology of two members of a German-American kindred (Family C) with late onset parkinsonism.
Wszolek K, Gwinn-Hardy K, Muenter D, Pfeiffer F, Rodnitzky L, Uitti J, McComb D, Gasser T, Dickson W, Acta Neuropathol
Mutation at the SCA17 locus is not a common cause of parkinsonism.
Hernandez D, Melissa Hanson M, Singleton A, Gwinn-Hardy K, Freeman J, Doheny D, Gallardo M, Weiser R, Hardy J, Singleton A, Parkinsonism Relat Disord
alpha-Synuclein locus triplication causes Parkinson's disease.
Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, Hardy J, Gwinn-Hardy K, Science
Spinocerebellar ataxia type 2 (SCA2) may present as levodopa-responsive parkinsonism.
Payami H, Nutt J, Gancher S, Bird T, McNeal M, Selzer WK, Lockhart P, Gwinn-Hardy K, Hussey J, Singleton AA, Singleton AB, Hardy J, Farrer M, Mov Disord
Clinical, 18F-dopa PET, and genetic analysis of an ethnic Chinese kindred with early-onset parkinsonism and parkin gene mutations.
Wu RM, Shan DE, Sun CM, Liu RS, Hwu WL, Tai CH, Hussey J, West A, Gwinn-Hardy K, Hardy J, Chen J, Farrer M, Sarah Lincoln S, Mov Disord
No pathogenic mutations in the beta-synuclein gene in Parkinson’s disease.
Lincoln S, Crook R, Chartier-Harlin MC, Gwinn-Hardy K, Baker M, Mouroux V, Richard F, Becquet E, Amouyel P, Destee A, Hardy J, Farrer M, Neurosci Lett
No pathogenic mutations in the persyn gene in Parkinson's disease.
Lincoln S, Gwinn-Hardy K, Goudreau J, Chariter-Harlin MC, Lynch T, Hardy J, Farrer M, Neurosci Lett
Low frequency of pathogenic mutations in the ubiquitin carboxy terminal hydrolase gene in familial Parkinson’s disease.
Lincoln S, Vaughan J, Wood N, Baker M, Adamson J, Gwinn-Hardy K, Lynch T, Hardy J, Farrer M, NeuroReport
Electrophysiological observations in hereditary parkinsonism-dementia with Lewy body pathology.
Caviness JN, Gwinn-Hardy K, Adler CH, Muenter MD, Mov Disord
Amantadine is beneficial in Restless Legs Syndrome.
Evidente VG, Adler CH, Caviness JN, Hentz JG, Gwinn-Hardy K, Mov Disord
Hereditary spinocerebellar ataxias: a clinicogenetic review.
Evidente VGH, Gwinn-Hardy KA, Gilman S, Mayo Clin Proc
Spinocerebellar ataxia type 2 with parkinsonism in ethnic Chinese.
Gwinn-Hardy K, Chen Y, Liu H, Liu TY, Boss M, Seltzer W, Adam A, Singleton A, Hardy J, Waters C, Farrer M, Neurology
Distinctive neuropathology revealed by anphasynuclein antibodies in hereditary parkinsonism and dementia linked to chromosome 4p.
Gwinn-Hardy K, Mehta ND, Farrer M, Maraganore D, Muenter M, Hardy J, Dickson D, Acta Neuropathol
Female hormonal effects symptom severity in women with dystonia.
Gwinn-Hardy KA, Adler CH, Weaver A, Fish N, Cox SJ, Mayo Clin Proc
A kindred with Parkinson’s disease not showing linkage to established loci.
Gwinn-Hardy K, Crook R, Lincoln S, Adler CH, Caviness JN, Hardy J, Farrer M, Neurology
Neurofibrillary tangles, amyotrophy and progressive motor disturbance in tau mutant (P301L) transgenic mice.
Lewis J, McGowan E, Rockwood J, Melrose H, Nacharaju P, Van Slegtenhorst M, Gwinn-Hardy K, Murphy MP, Baker M, Yu X, Duff K, Hardy J, Corral A, Lin W-L, Yen S-H, Dicks..., Nature Genetics
Pain in Parkinson's disease - Common yet seldom recognized symptom is treatable.
Waseem S, Gwinn-Hardy K, Postgraduate Medicine
A clinical and pathological study of motor neuron disease on Guam.
Morris HR, Al-Sarraj S, Schwab C, Gwinn-Hardy K, Wood NW, Hardy J, Lees AJ, McGeer P, Daniel SE, Steele JC, Brain
Persistent chorea triggered by hyperglycemic crisis in new-onset diabetics.
Ahlskog JE, Evidente, VGH, Tulloch, JW, Forbes GS, Caviness JN, Gwinn-Hardy KA, Mov Disord
Serum leptin is normal in Parkinson’s disease patients with weight loss.
Evidente VGH, Caviness JNC, Adler CH, Gwinn-Hardy KA, Pratley R, Mov Disord
Lewy bodies and parkinsonism in families with parkin mutations.
Farrer M, Chan P, Chen R, Tan L, Lincoln S, Hernandez D, Forno L, Gwinn-Hardy K, Petrucelli L, Hussey J, Singleton A, Tanner C, Hardy J, Langston JW, Ann Neurol
Early cinematographic cases of post-encephalitic parkinsonism and other movement disorders.
Evidente VGH, Gwinn KA, Mulder DW, Caviness JN, Muenter MD, Mov Disord
Review: Genetic dissection of Alzheimer’s disease and related dementias: amyloid and its relationship to tau.
Hardy J, Duff K, Perez-Tur J, Gwinn-Hardy K, Hutton, M, Nature Neurosci
Join now to see all

Lectures

Genetic Lessons and New Approaches in Learning about Parkinson’s Disease(s).
Parkinson Disease Foundation Symposium
re: confusion and intracranial hemorrhage.
Grey’s Anatomy (ABC)
re: Post-Encephalitic Parkinsonism.
National Geographic
A prospective, randomized, parallel-group, double-blind, placebo-controlled multicenter study to evaluate the short-term efficacy and safety of Entacapone administered...
Novartis, Inc
An open-label, safety study of Neurobloc™ (botulinum toxin type B) in patients with cervical dystonia.
Athena Neurosciences Inc
Join now to see all